# A Long-Term Follow-up Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02

> **NCT04836377** · — · TERMINATED · sponsor: **AVROBIO** · enrollment: 4 (actual)

## Conditions studied

- Type 1 Gaucher Disease

## Interventions

- **OTHER:** Safety and efficacy assessments

## Key facts

- **NCT ID:** NCT04836377
- **Lead sponsor:** AVROBIO
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-06
- **Primary completion:** 2023-08-21
- **Final completion:** 2023-08-21
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** This study was voluntarily terminated due to a business decision not to proceed, and not due to any safety or efficacy issue
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04836377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04836377, "A Long-Term Follow-up Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04836377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*